Team:DTU-Denmark-2/Our Partners/Sponsors

From 2011.igem.org

(Difference between revisions)
Line 24: Line 24:
<p align="justify">
<p align="justify">
-
Novozymes is a Danish biotech companny and one of the world leading in production and discovery of new enzymes.  
+
Novozymes is a independent company established in 2000 under the Novo group. Novozymes are a Danish biotech company with the focus on sustainability in every aspect of the solutions the offer their costumers and are among the leading companies in production and discovery of new enzymes. Novozymes products facilitate solutions that ensure optimal processes and high quality products in various industries such as Argiculture, biopharma, textile ect.
 +
 
</p>
</p>
</td>
</td>

Revision as of 10:31, 8 September 2011



Sponsors

Novozymes is a independent company established in 2000 under the Novo group. Novozymes are a Danish biotech company with the focus on sustainability in every aspect of the solutions the offer their costumers and are among the leading companies in production and discovery of new enzymes. Novozymes products facilitate solutions that ensure optimal processes and high quality products in various industries such as Argiculture, biopharma, textile ect.

Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases, with focus is on cancer, biodefence and infectious deceases. Bavian Nordic is in the early stage of development of a HIV and RSV and this days working with their proof of concept. The immunotherapy targeting breast and prostata cancer has shown beneficial and promising results.

ALK was established in the beginning of the 1920'ies first as a part of a pharmacy and then later it became a independent company. ALK's main focus are on the prevention, diagnosis and treatment of allergies and are a global leading company in allergy vaccinations. ALK's research are ground breaking and one of ALK's treatments are recognized by WHO as the only treatment that can change the underlying allergic disease.

Novo Nordisk already toke it's origin in 1922 and after fusion of the two companies in 1989, it became fast growing and a global healthcare company with many years of innovation and leadership in diabetes care. Novo Nordisk also has leading research within haemophilia care, growth hormone therapy and hormone replacement therapy.

DNA Technologies was established in 1992 and are today among the leading manufactures and suppliers of costume designed oligonucleotides. Besides the manufactory of oligoneucleotides, DNA technology provide a wide range of different services for the costumers including DNA sequencing and distribution of molecular bioagents.

Integrated DNA technology was established in 1987 and are among the leading manufactures and developers in the research field of biotechnology and pharmaceuticals. IDT is recognized as the industry leader in manufacturing oligonucleotides due to their compatibility in analytic sophistication, design engineering, costume support, information technology and with day to day delivery.

Pharmadanmark was established in 1873 and is a union gathering academics within the pharmaceutical field. Pharmadanmarks goal is to provide its members with the best conditions during and after graduation in the terms of professional development, employment, salary and career development. Additionally, Pharmadanmark also provide benefits to their members in form of cheap insurances, counseling, coaching and other financial support.